[
    [
        {
            "time": "",
            "original_text": "阿斯利康新冠疫苗风波又起，拿下中国代理权的康泰生物还好吗？",
            "features": {
                "keywords": [
                    "阿斯利康",
                    "新冠疫苗",
                    "风波",
                    "康泰生物"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "阿斯利康新冠疫苗风波又起，拿下中国代理权的康泰生物还好吗？",
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "智飞生物、康泰生物极速跳水，疫苗板块回落",
            "features": {
                "keywords": [
                    "智飞生物",
                    "康泰生物",
                    "跳水",
                    "疫苗板块",
                    "回落"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "智飞生物、康泰生物极速跳水，疫苗板块回落",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 9,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-01-01",
            "original_text": "2021年1-2月疫苗批签发数据跟踪报告：二类疫苗快速增长，热门大品种表现亮眼",
            "features": {
                "keywords": [
                    "疫苗",
                    "批签发",
                    "二类疫苗",
                    "快速增长",
                    "热门大品种"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "2021年1-2月疫苗批签发数据跟踪报告：二类疫苗快速增长，热门大品种表现亮眼",
                "Correlation": 7,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 4
            }
        }
    ]
]